Early diabetes drug test: does new pill change how metformin works?
NCT ID NCT07433062
Summary
This early-stage study aims to understand how a new investigational drug, AZD6793, interacts with the common diabetes medication metformin. It will involve about 28 people with type 2 diabetes who are already taking metformin. The main goal is to see if AZD6793 changes how the body processes metformin and if it affects blood sugar control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGNeuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.